An oxyphenbutazone is a metabolite formed by hydroxylation at position 4 of the phenyl ring in phenylbutazone. In 1984, the drug was withdrawn from the market due to its association with blood dyskrasis and Stevens-Johnson syndrome. It was used as…   Read more»